Cytiva

Cytiva is a global biotechnology leader committed to advancing the discovery, development, and commercialization of next-generation therapeutics. As part of Danaher, Cytiva leverages its deep technical expertise and a comprehensive portfolio of tools, technologies, and services to empower customers in bringing transformative medicines to patients.

Operating globally, Cytiva is dedicated to accelerating the impact of science and technology innovation to improve human health. With multiple locations worldwide, including its primary address in Global, Global 000000, OO, Cytiva is strategically positioned to serve its diverse customer base. Further locations include Björkgatan 30, Fålhagen, Uppsala County 753 23, SE; Amersham Place, Little Chalfont, England HP7 9, GB; and 100 Results Way, Marlborough, Massachusetts 01752, US, among others.

Cytiva continues to enhance its capabilities and expand its offerings to meet the evolving needs of the biotechnology industry. The company’s management is actively working to provide more detailed information about its innovative solutions and services, ensuring that Cytiva remains at the forefront of biotechnology advancements. We invite the manager of Cytiva to create a customized and exclusive company showcase and product listing on our platform to further highlight Cytiva's contributions and capabilities.